Anxiety Disorders and Depression Treatment Market Is on a Decline Due to Patent Expiry of Major Antidepressants
Anxiety disorders and depression are common psychiatric disorders that affect a large number of people during their lifetime. This study provides the market analysis for the major drug classes used for the treatment of anxiety disorders and depression. The stakeholders of this report include established pharmaceutical companies as well as new entrants who wish to enter the market.
View full press release